Results 31 to 40 of about 28,557 (262)

Diagnostic Research of CT Combined with Serum CA125 and HE4 in Ovarian Epithelial Malignant Tumor

open access: yesCT Lilun yu yingyong yanjiu, 2022
Objective: To explore the diagnostic value of CT combined with serum CA125 and HE4 in ovarian epithelial malignant tumor. Methods: 156 cases of epithelial ovarian tumors (benign 72 cases, malignant 84 cases) were studied. Detections of CT and serum tumor
Desheng WANG, Fanggong KAN, Zhoupeng MA
doaj   +1 more source

Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study

open access: yesBJOG: an International Journal of Obstetrics and Gynaecology, 2023
To investigate serum human epididymis‐4 (HE4) as a predictive biomarker of intrauterine progestin response in endometrial cancer and atypical endometrial hyperplasia (AEH).
Chloe E. Barr   +5 more
semanticscholar   +1 more source

Detection of serum HE4 levels contributes to the diagnosis of lung cancer

open access: yesOncology Letters, 2023
Lung cancer (LC) is the most frequently diagnosed cancer and is the leading cause of cancer-associated death. Serum markers that exhibit high sensitivity and specificity for LC may assist in the diagnosis and prognosis of LC.
Jun Li   +10 more
semanticscholar   +1 more source

Evaluation of tumor marker HE4 assay on the Elecsys 2010 analyzer

open access: yesJournal of Health Sciences, 2014
Introduction: Whey-acidic protein human epididymis protein 4 (HE4) is a new promising biomarker for epithelial ovarian cancer. The measured HE4 values may depend on the testing procedure used.
Jozo Ćorić   +3 more
doaj   +1 more source

Value of human epididymis secretory protein 4 in differentiating malignant from benign pleural effusion: an analysis of two cohorts

open access: yesTherapeutic Advances in Respiratory Disease, 2023
Background: Lung cancer is the most common cause of malignant pleural effusion (MPE). Serum human epididymis secretory protein 4 (HE4) is a useful diagnostic marker for lung cancer.
Qian Yang   +11 more
doaj   +1 more source

Big Bang Nucleosynthesis: an accurate determination of light element yields [PDF]

open access: yes, 1999
We report the results of a new accurate evaluation of light nuclei yields in primordial nucleosynthesis. All radiative effects, finite nucleon mass, thermal and plasma corrections are included in the proton to neutron conversion rates.
Ahmed   +59 more
core   +2 more sources

Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Introduction: Endometrial Cancer (EC) is a common female malignant disorder. To date, there are no specific tumour markers for EC that may be routinely used in clinical practice for diagnosis. Aim: To evaluate the diagnostic performance of the serum
Rupali Dewan   +4 more
doaj   +1 more source

The Primordial Abundance of He4: An Update [PDF]

open access: yes, 1996
We include new data in an updated analysis of helium in low metallicity extragalactic HII regions with the goal of deriving the primordial abundance of He4 (Y_P).
Brocklehurst M.   +16 more
core   +2 more sources

Dapagliflozin Attenuates Contrast-induced Acute Kidney Injury by Regulating the HIF-1α/HE4/NF-κB Pathway

open access: yesJournal of Cardiovascular Pharmacology, 2022
Supplemental Digital Content is Available in the Text. Abstract: Contrast-induced acute kidney injury (CI-AKI) causes clinically acquired nephropathy in patients who undergo coronary interventions. Hypoxic injury to proximal tubular epithelial cells is a
Xuan Huang   +10 more
semanticscholar   +1 more source

Comparison of the diagnostic accuracy of HE4 with CA125 and validation of the ROMA index in differentiating malignant and benign epithelial ovarian tumours among patients in Lagos, Nigeria

open access: yesecancermedicalscience, 2023
This prospective cross-sectional study compared the diagnostic accuracy of human epididymal protein 4 (HE4) with cancer antigen 125 (CA 125) and validates the risk of malignancy algorithm (ROMA) in differentiating benign from malignant ovarian tumours ...
K. A. Shittu   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy